CHC Healthcare Group (TPE:4164)

Market Cap	5.72B -27.4%
Revenue (ttm)	4.55B +15.2%
Net Income	204.07M +16.9%
EPS	1.05 +4.0%
Shares Out	195.31M
PE Ratio	27.88
Forward PE	16.74
Dividend	1.10 (3.83%)
Ex-Dividend Date	Jun 29, 2026

Volume	595,399
Open	28.75
Previous Close	28.75
Day's Range	28.55 - 29.90
52-Week Range	27.85 - 52.30
Beta	0.18
Analysts	Hold
Price Target	43.00 (+46.76%)
Earnings Date	Aug 6, 2026

About CHC Healthcare Group

CHC Healthcare Group, together with its subsidiaries, trades in medical equipment, pharmaceutical products, and health food in Taiwan, China, and internationally. The company is also involved in the leasing, installing, servicing, and repairing of medical instruments for use in various specialties, such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, robot rehabilitation, dentistry, and smart health care. In addition, it engages in the irradiation business; sale of daily necessities, beauty products, and health supple...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4164

Financial Performance

In 2025, CHC Healthcare Group's revenue was 4.40 billion, an increase of 22.15% compared to the previous year's 3.60 billion. Earnings were 186.28 million, an increase of 10.63%.